Literature DB >> 26187018

Intra- and Interinstitutional Evaluation of an Etest for Vancomycin Minimum Inhibitory Concentration Measurement in Staphylococcus aureus Blood Isolates.

Rocío Falcón1, Silvia Madrid1, Nuria Tormo2, Cristina Casañ2, Eliseo Albert1, Concepción Gimeno3, David Navarro4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26187018     DOI： 10.1093/cid/civ583

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  6 in total

1.  Reproducible measurement of vancomycin MICs within the susceptible range in Staphylococcus aureus by a broth microdilution method with a "quasi-continuum" gradient of antibiotic concentrations.

Authors:  R Falcón; E M Mateo; A Talaya; E Giménez; V Vinuesa; M Á Clari; D Navarro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-07-25       Impact factor: 3.267

2.  Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus.

Authors:  Rocío Falcón; Eva Mateo; Rosa Oltra; Estela Giménez; Eliseo Albert; Ignacio Torres; David Navarro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-02-06       Impact factor: 3.267

3.  Genotypic and Phenotypic Characteristics of Staphylococcus aureus Prosthetic Joint Infections: Insight on the Pathogenesis and Prognosis of a Multicenter Prospective Cohort.

Authors:  Irene Muñoz-Gallego; Esther Viedma; Jaime Esteban; Mikel Mancheño-Losa; Joaquín García-Cañete; Antonio Blanco-García; Alicia Rico; Adelaida García-Perea; Patricia Ruiz Garbajosa; Rosa Escudero-Sánchez; Mar Sánchez Somolinos; Mercedes Marín Arriaza; Juan Romanyk; José María Barbero; Ana Arribi Vilela; Fernando González Romo; Conchita Pérez-Jorge; David M Arana; Alfonso Monereo; Diego Domingo; José Cordero; Mª Isabel Sánchez Romero; Miguel Ángel García Viejo; Jaime Lora-Tamayo; Fernando Chaves
Journal:  Open Forum Infect Dis       Date:  2020-08-13       Impact factor: 3.835

4.  Impact of Vancomycin MIC on Treatment Outcomes in Invasive Staphylococcus aureus Infections.

Authors:  Kyoung-Ho Song; Moonsuk Kim; Chung Jong Kim; Jeong Eun Cho; Yun Jung Choi; Jeong Su Park; Soyeon Ahn; Hee-Chang Jang; Kyung-Hwa Park; Sook-In Jung; Nara Yoon; Dong-Min Kim; Jeong-Hwan Hwang; Chang Seop Lee; Jae Hoon Lee; Yee Gyung Kwak; Eu Suk Kim; Seong Yeon Park; Yoonseon Park; Kkot Sil Lee; Yeong-Seon Lee; Hong Bin Kim
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

5.  Effect of the vancomycin minimum inhibitory concentration on clinical outcomes in patients with methicillin-susceptible Staphylococcus aureus bacteraemia: a systematic review and meta-analysis.

Authors:  Changcheng Shi; Jian Ye; Renjie Xu; Weizhong Jin; Shuang Xu; Fei Teng; Nengming Lin
Journal:  BMJ Open       Date:  2021-01-15       Impact factor: 2.692

6.  High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus.

Authors:  Rafael San-Juan; Esther Viedma; Fernando Chaves; Antonio Lalueza; Jesús Fortún; Elena Loza; Miquel Pujol; Carmen Ardanuy; Isabel Morales; Marina de Cueto; Elena Resino-Foz; Alejandra Morales-Cartagena; Alicia Rico; María P Romero; María Ángeles Orellana; Francisco López-Medrano; Mario Fernández-Ruiz; José María Aguado
Journal:  Emerg Infect Dis       Date:  2016-06       Impact factor: 6.883
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.